Navigation Links
Reckitt Benckiser Completes Acquisition of Adams Respiratory Therapeutics, Inc.
Date:1/30/2008

CHESTER, N.J. and SLOUGH, England, Jan. 30 /PRNewswire/ -- Reckitt Benckiser Group plc (RB.L) ("Reckitt Benckiser") today announced the successful completion of its acquisition of Adams Respiratory Therapeutics, Inc. (Nasdaq: ARxT) ("Adams") through a cash tender offer followed by a short- form merger of its indirect wholly owned subsidiary, Twickenham Inc., with and into Adams. As a result of this acquisition, Adams becomes an indirect wholly owned subsidiary of Reckitt Benckiser.

At the effective time of the merger, all outstanding shares of Adams common stock not validly tendered and accepted for payment in the tender offer were converted into the right to receive US$60.00 per share in cash (the same price paid in the tender offer), without interest and subject to applicable withholding of taxes. American Stock Transfer & Trust Company, acting as the paying agent for the merger, will mail to the remaining former shareholders of Adams materials necessary to exchange their former Adams shares for such payment. As a result of the merger, Adams shares will be delisted and cease to trade on the NASDAQ Global Select Market.

Notes for Editors

Reckitt Benckiser is a world leader in household cleaning, health and personal care. The Company is truly global, with over 60 operating companies and some 43 manufacturing facilities worldwide and has sales in 180 countries. Reckitt Benckiser employs 22,000 people around the world. Amongst the Company's leading brands in household are Lysol, the world leader in disinfecting cleaning, Calgonit & Finish & Electrasol, the world leaders in automatic dishwashing, Woolite, world leader in fine fabrics, Vanish & Spray'n Wash, world leaders in fabric treatment, Airwick and Mortein, both No.
'/>"/>

SOURCE Reckitt Benckiser
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Reckitt Benckiser Commences Cash Tender Offer for All Outstanding Shares of Adams Respiratory Therapeutics
2. Flextronics Completes Acquisition of Avail
3. Symmetry Medical Completes Acquisition of DePuy Orthopaedic Instrument Facility
4. Cardiac Science Completes Deployment of AEDs With Los Angeles County Fire Department
5. Edwards Lifesciences Completes Sale of LifeStent Product Line to Bard
6. Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
7. Specialty Blades, Inc. Completes Acquisition of Popper and Sons, Inc.
8. PolyOne Completes Acquisition of GLS Corporation
9. SPX Corporation Completes Acquisition of APV
10. Cell Therapeutics, Inc. (CTI) Completes Acquisition of Lymphoma Drug Zevalin(R) From Biogen Idec for Sales and Marketing in the United States
11. The Carlyle Group Completes Transaction with Manor Care
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 2Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 3Vivakor Announces New Acquisition Strategy 2Confusion Over Homeopathic Medicines in Alexa Ray Joel's Hospitalization Clarified by the American Association of Homeopathic Pharmacists (AAHP) 2Affymetrix Reports Second Quarter 2009 Results 52465 1Affymetrix Reports Second Quarter 2009 Results 52465 2Affymetrix Reports Second Quarter 2009 Results 52465 3Affymetrix Reports Second Quarter 2009 Results 52465 4Affymetrix Reports Second Quarter 2009 Results 52465 5Affymetrix Reports Second Quarter 2009 Results 52465 6Affymetrix Reports Second Quarter 2009 Results 52465 7Affymetrix Reports Second Quarter 2009 Results 52465 8Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 1Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 2Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 3Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 4Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 5Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 6Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 7Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 8Universal Health Realty Income Trust Reports 2009 Second Quarter Financial Results 52457 1Universal Health Realty Income Trust Reports 2009 Second Quarter Financial Results 52457 2Universal Health Realty Income Trust Reports 2009 Second Quarter Financial Results 52457 3Universal Health Realty Income Trust Reports 2009 Second Quarter Financial Results 52457 4Universal Health Realty Income Trust Reports 2009 Second Quarter Financial Results 52457 5Universal Health Realty Income Trust Reports 2009 Second Quarter Financial Results 52457 6Universal Health Realty Income Trust Reports 2009 Second Quarter Financial Results 52457 7Universal Health Realty Income Trust Reports 2009 Second Quarter Financial Results 52457 8Universal Health Realty Income Trust Reports 2009 Second Quarter Financial Results 52457 9